<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Acorda Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Acorda Therapeutics, Inc.

    Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cohen, MD
    • FOUNDED
      1995
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnolog...

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS)...

    Filing Type:    PU
    Inogen, Inc

    Inogen, Inc

    Inogen’s mission to improve the quality of life of supplemental oxygen users beg...

    Inogen’s mission to improve the quality of li...

    Filing Type:    PU
    InVivo Therapeutics Holdings Corp.

    InVivo Therapeutics Holdings Corp.

    Armed with cutting-edge technology and MIT science, experienced business and medic...

    Armed with cutting-edge technology and MIT scie...

    Filing Type:    PU
    Magenta Therapeutics, Inc.

    Magenta Therapeutics, Inc.

    Magenta Therapeutics is a clinical-stage biotechnology company developing therapeu...

    Magenta Therapeutics is a clinical-stage biotec...

    Filing Type:    PU
    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...

    NeuBase Therapeutics, Inc. is developing its mo...

    Filing Type:    PU
    Motif Bio plc

    Motif Bio plc

    Motif Bio is a clinical stage biopharmaceutical company developing novel antibioti...

    Motif Bio is a clinical stage biopharmaceutical...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.